Analysis of a novel mechanism for the post-transcriptional regulation of protein kinase Hipk2 expression
Analysis of a novel mechanism for the post-transcriptional regulation of protein kinase Hipk2 expression
批准号:
281666681
负责人:
Professor Dr. Karl-Heinz Klempnauer
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2015
资助国家:
德国
项目状态:
已结题
起止时间:
2014-12-31 至 2019-12-31
中文摘要
这里描述的项目涉及新的发现的功能的蛋白激酶Hipk2和肿瘤抑制因子Pdcd4的转录后调节Hipk2的表达。我们的初步工作表明,Hipk2和Pdcd4通过一种新的机制参与了Hipk2 mRNA翻译的拮抗调节。我们已经发现,Hipk2 mRNA的翻译是由Hipk2本身以自动调节的方式刺激的,Pdcd4破坏了这种自动调节机制,从而抑制Hipk2的表达。这第一次表明,Hipk2的表达不仅是由蛋白酶体降解控制,目前假设,但它也可以通过其合成调节。这表明了Hipk2的另一个调节水平,迄今为止还没有研究过。此外,我们的初步工作表明,Pdcd4调节Hipk2的合成,从而可能影响Hipk2调节的过程。通过使用Pdcd4突变体,我们还发现Pdcd4对Hipk2 mRNA翻译的抑制必须通过一种新的机制发生,该机制不同于先前描述的Pdcd4抑制翻译的机制。本项目的目的是研究Hipk2和Pdcd4对Hipk2 mRNA翻译的拮抗作用,以了解这两种蛋白在翻译调控中的新作用的分子基础。这些机制的表征将导致新的洞察这些高度保守的蛋白质在正常和肿瘤细胞中的功能。
英文摘要
The project described here deals with novel findings on the function of the protein kinase Hipk2 and the tumor suppressor Pdcd4 in the post-transcriptional regulation of Hipk2 expression. Our preliminary work has shown that Hipk2 and Pdcd4 are involved in the antagonistic regulation of the translation of Hipk2 mRNA by a novel mechanism. We have found that the translation of Hipk2 mRNA is stimulated in an autoregulatory manner by Hipk2 itself and that Pdcd4 disrupts this autoregulatory mechanism, thereby inhibiting Hipk2 expression. This demonstrates for the first time that Hipk2 expression is not only controlled by proteasomal degradation, as presently assumed, but that it can also be regulated by its synthesis. This points to an additional level of regulation of Hipk2, which has not been investgated so far. Furthermore, our preliminary work has shown that Pdcd4 modulates the synthesis of Hipk2 and thereby might influence Hipk2-regulated processes. By using Pdcd4 mutants we have also found that the inhibition of Hipk2 mRNA translation by Pdcd4 must occur by a novel mechanism that is distinct from the previously described mechanisms of translation suppression by Pdcd4. The aim of this project is to study the antagonistic effects of Hipk2 and Pdcd4 on the translation of Hipk2 mRNA in order to understand the molecular basis into these novel roles of both proteins in the regulation of translation. The characterization of these mechanisms will lead to novel insight into the function of these highly conserved proteins in normal and in tumor cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterization of target RNAs of the tumor suppressor protein Pdcd4
-
批准号:315564788
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Professor Dr. Karl-Heinz Klempnauer
-
依托单位:
Characterizaton of the chromatin remodelling activity of the transcription factor c-Myb
-
批准号:246701844
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Professor Dr. Karl-Heinz Klempnauer
-
依托单位:
Untersuchungen zur Rolle des Tumorsuppressors Pdcd4 bei der zellulären Antwort auf DNA-Schädigung
-
批准号:187149287
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Professor Dr. Karl-Heinz Klempnauer
-
依托单位:
Investigation of novel interaction partners of the transcription factor B-Myb and the role of B-Myb in the DNA-damage response
-
批准号:30492185
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2006
-
负责人:Professor Dr. Karl-Heinz Klempnauer
-
依托单位:
Analysis of the "de novo" chromatin opening induced by C/EBPß
-
批准号:5451888
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2005
-
负责人:Professor Dr. Karl-Heinz Klempnauer
-
依托单位:
Phosphorylation of the transcription factor C/EBPß and the coactivator p300
-
批准号:5410414
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2003
-
负责人:Professor Dr. Karl-Heinz Klempnauer
-
依托单位:
Charakterisierung der Zielgene des Transkriptionsfaktors c-Myb
-
批准号:5391640
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2002
-
负责人:Professor Dr. Karl-Heinz Klempnauer
-
依托单位:
Analyse der Zellzyklusfunktion des B-myb Gens
-
批准号:5095092
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:Professor Dr. Karl-Heinz Klempnauer
-
依托单位:
Regulation der Aktivität des Transkriptionsfaktors C/EBPbeta durch nukleäre Effektoren
-
批准号:5090384
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:Professor Dr. Karl-Heinz Klempnauer
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Novel-miR-1134调控LHCGR的表达介导拟
穴青蟹卵巢发育的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:崔文晓
-
依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
-
批准号:82304677
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:边兴博
-
依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
-
批准号:82304658
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘亚
-
依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
-
批准号:32102747
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李婉雁
-
依托单位:
novel_circ_001042/miR-298-5p/Capn1轴调节线粒体能量代谢在先天性肛门直肠畸形发生中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:唐晓冰
-
依托单位:
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:张瑜
-
依托单位:
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
-
批准号:82070530
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:白玉作
-
依托单位:
miRNA-novel-272通过靶向半乳糖凝集素3调控牙鲆肠道上皮细胞炎症反应的机制研究
-
批准号:32002421
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:修云吉
-
依托单位:
m6A修饰介导的lncRNA WEE2-AS1转录后novel-pri-miRNA剪切机制在胶质瘤恶性进展中的作用研究
-
批准号:82072775
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:薛皓
-
依托单位:
miRNA/novel_167靶向抑制Dmrt1的表达在红鳍东方鲀性别分化过程中的功能研究
-
批准号:31902347
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2019
-
负责人:闫红伟
-
依托单位: